Methylene blue, midodrine, and pseudoephedrine: a review of alternative agents for refractory hypotension in the intensive care unit

Critical Care Nursing Quarterly
Megan A Van BerkelG Morgan Jones

Abstract

Hypotensive episodes are common among patients in the intensive care unit and can lead to multiorgan failure if uncontrolled. Fluid administration and continuous infusion of vasoactive agents are frequently used for management of hypotension; however, both therapies may be associated with adverse effects including pulmonary edema and tissue necrosis. In addition, availability of these first-line agents has been impacted by the increasing occurrence of drug shortages. Methylene blue, pseudoephedrine, and midodrine have been considered potential alternatives to standard therapy. These agents may not only be used when first-line agents are unavailable due to shortages, but they may also aid in reducing the cumulative dose of other vasoactive agents used. The purpose of this review was to discuss strategies for the safe and effective use of methylene blue, pseudoephedrine, and midodrine for the treatment of hypotension in the critically ill.

References

Feb 1, 1995·Critical Care Medicine·J C PreiserJ L Vincent
Aug 1, 1995·Critical Care Medicine·C R Daemen-GubbelsL G Thijs
Oct 1, 1996·Postgraduate Medical Journal·G BrownT Phang
Aug 1, 1997·Annals of Emergency Medicine·P R EvoraP M Schiaveto
Dec 10, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R WeingartnerG Friedman
Jun 28, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G PeerA Iaina
Oct 6, 2001·Critical Care Medicine·M Y KirovL J Bjertnaes
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Feb 5, 2004·The Annals of Thoracic Surgery·Ricardo L LevinFernando J Boullon
Jan 27, 2005·Annals of Emergency Medicine·Alex F ManiniTodd W Thomsen
Apr 12, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Sanjiv Sharma, Brijesh Bhambi
Sep 2, 2005·The Korean Journal of Internal Medicine·Byung-Kyu ParkYounsuck Koh
Nov 11, 2006·Journal of Intensive Care Medicine·Edmund S H Kwok, Daniel Howes
Feb 6, 2008·Circulation·Harmony R Reynolds, Judith S Hochman
Mar 21, 2008·Journal of Burn Care & Research : Official Publication of the American Burn Association·Amín D JaskilleMarion H Jordan
May 23, 2008·Journal of Cardiovascular Pharmacology and Therapeutics·Sanjiv SharmaBrijesh Bhambi
Jan 30, 2010·Nitric Oxide : Biology and Chemistry·Nicole P JuffermansA B Johan Groeneveld
Jun 26, 2010·Pharmacotherapy·Christopher A PaciulloJeremy D Flynn
Aug 14, 2010·Seminars in Cardiothoracic and Vascular Anesthesia·Dominique Lavigne
Jan 20, 2011·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Tristan C DumbartonRobert Green
May 7, 2011·Annals of Emergency Medicine·David H JangRobert S Hoffman
Mar 6, 2012·The Annals of Pharmacotherapy·Tristan Charles DumbartonRobert Green
Jun 30, 2012·Plastic and Reconstructive Surgery·Aviram M Giladi, Steven J Kasten
Sep 18, 2012·The Journal of Thoracic and Cardiovascular Surgery·Kendra J GrubbJohn A Kern
Oct 2, 2012·International Journal of Cardiology·Uğur CanpolatAli Oto
Oct 3, 2012·Critical Care Nurse·JoAnn Grif Alspach
Dec 4, 2012·Critical Care Nurse·Joann Grif Alspach
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Dec 25, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·J FisherA Graudins
Mar 4, 2014·Mayo Clinic Proceedings·Erin R FoxValerie Jensen

❮ Previous
Next ❯

Citations

Dec 7, 2018·Pharmacotherapy·Mitchell S BuckleySandra L Kane-Gill
Jul 1, 2016·The International Journal of Neuroscience·Cristina TassorelliGiorgio Sandrini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.